Synthesis and structural study of highly constrained hybrid
677
stirring at room temperature for 2 h the reaction crude was
washed with a saturated aqueous sodium bicarbonate
solution. The organic phase was dried over magnesium
sulfate and the solvents were removed under vacuum. The
reaction crude was purified by column chromatography on
neutral silica gel (ethyl acetate/hexane 1:1) to afford pure
dipeptide (14). Yield 276 mg (95%). White solid. mp 59–
H
11 and H28), 4.48 (m, 1H, H14), 5.04 (d, J = 12.3 Hz, 1H,
H36 CH2), 5.12 (d, J = 12.3 Hz, 1H, H36 CH2), 6.80 (d,
J = 7.1 Hz, 1H, H35), 7.32–7.38 (m, 5H, H36 Ar), 7.63–7.72
(m, 3H, H9, H18 and H26). 13C NMR (150 MHz; CDCl3):
17.0 (C25), 17.3 (C8), 25.8 (C4), 26.3 (C21), 28.4 (6C, C17,
C34), 28.8 (C24), 29.0 (C7), 31.9 (C15), 32.1 (C32), 43.0 (C3),
44.7 (C20), 45.6 and 45.9 (2C, C25, C6), 49.0 (C1), 49.9 (2C,
C5, C22), 50.7 (C31), 51.7 (C14), 55.2 (2C, C13, C30), 59.2 (2C,
C11, C28), 66.6 (C36 CH2), 81.2 and 81.3 (2C, C17q, C34q),
128.1, 128.3 and 128.5 (C36 Ar), 136.6 (C36q), 156.1 and
156.2 (3C, C16, C33, C36 CO), 171.1 (C19), 172.1 (C27), 172.5
(C10), 173.0 (C2). IR (ATR, cmax cm-1) 3,640, 3,571, 3,292,
2,956, 1,665, 1,524, 1,391, 1,368. HRMS (ESI) calculated
for C43H65N6O11 [M ? H]? 841.4706; found: 841.4698.
62°C (from Et2O). ½aꢁ20 -109.4 (c 0.39, CH2Cl2) (see Fig. 6
D
1
for numbering). H NMR (600 MHz; CDCl3): 0.95 (s, 3H,
H7), 1.28 (s, 3H, H8), 1.47 (s, 9H, H17), 2.11 (m, 1H,
H4 proS), 2.16 (m, 1H, H15 proS), 2.32 (m, 1H, H4 proR), 2.38
(m, 1H, H15 proS), 2.61 (dd, J = J0 = 8.9 Hz, 1H, H3), 3.45
(dd, J = J0 = 10.8 Hz, 1H, H13 proS), 3.54 (dd,
J = 10.8 Hz, J0 = 4.8 Hz, 1H, H13 proR), 3.69 (s, 3H, H1),
4.06 (dd, J = 17.2 Hz, J0 = 8.5 Hz, 1H, H5), 4.30 (m, 1H,
H14), 4.42 (d, J = 8.8 Hz, 1H, H11), 5.06 (d, J = 12.3 Hz,
1H, H19 CH2), 5.13 (d, J = 12.3 Hz, 1H, H19 CH2), 6.68
(d, J = 6.4 Hz, 1H, H18), 7.32–7.37 (m, 5H, H19 Ar), 7.67
(d, J = 7.6 Hz, 1H, H9). 13C NMR (150 MHz; CDCl3):
17.2 (C8), 26.3 (C4), 28.3 (3C, C17), 28.8 (C7), 31.8 (C15),
43.1 (C3), 46.0 (C6), 50.0 (C5), 50.7 (C14), 51.5 (C1), 55.1
(C13), 59.2 (C11), 66.5 (C19 CH2), 81.2 (C17q), 128.0, 128.2
and 128.5 (C19 Ar), 136.7 (C19q), 156.0 (C19 CO), 156.3
(C16), 172.1 (C2), 172.9 (C10). IR (ATR, cmax cm-1) 3,305,
2,958, 1,679, 1,671, 1,541, 1,406. HRMS (ESI) calculated
for C26H37N3O7 [M ? Na]? 526.2524; found: 526.2504.
c-Hexapeptide (16)
Acid (15a) (90 mg, 0.10 mmol), DIPEA (0.06 mL,
0.30 mmol) and PyBOP (80 mg, 0.15 mmol) were dis-
solved in anhydrous dichloromethane (10 mL). The mix-
ture was stirred for 5 min under nitrogen atmosphere, and
then a solution of amine (14b) (60 mg, 0.10 mmol) in
anhydrous dichloromethane (5 mL) was added via cannula.
After stirring at room temperature for 2 h the reaction
crude was washed with a saturated aqueous sodium
bicarbonate solution. The organic phase was dried over
magnesium sulfate and the solvents were removed under
vacuum. The reaction crude was purified by column
chromatography on neutral silica gel (ethyl acetate to ethyl
acetate/methanol 19:1) to afford pure hexapeptide (16).
Yield 100 mg (84%). White solid. mp 144–146°C (from
c-Tetrapeptide (15)
Acid (14a) (160 mg, 0.33 mmol), DIPEA (0.2 mL,
1.00 mmol) and PyBOP (280 mg, 0.50 mmol) were dis-
solved in anhydrous dichloromethane (15 mL). The mixture
was stirred for 5 min under nitrogen atmosphere, and then a
solution of amine (14b) (120 mg, 0.33 mmol) in anhydrous
dichloromethane (5 mL) was added via cannula. After stir-
ring at room temperature for 2 h the reaction crude was
washed with a saturated aqueous sodium bicarbonate solu-
tion. The organic phase was dried over magnesium sulfate
and the solvents were removed under vacuum. The reaction
crude was purified by column chromatography on neutral
silica gel (ethyl acetate) to afford pure tetrapeptide (15) Yield
255 mg (92%). White solid. mp 129–131°C (from Et2O).
20
AcCN/H2O). ½aꢁD -131 (c 0.13, CH2Cl2) (see supple-
mentary material for numbering). 1H NMR (600 MHz;
CDCl3): 0.93–0.97 (m, 9H, H8, H25 and H42), 1.21–1.31
(m, 9H, H7, H24 and H41), 1.44–1.46 (m, 27H, H17, H34 and
H51), 2.10–2.44 (m, 14H, H4, H15, H21, H32, H38, H49, H20
and H37), 2.64 (m, 1H, H3), 3.37–3.53 (m, 6H, H13, H30 and
H47), 3.69 (s, 3H, H1), 4.02–4.07 (m, 3H, H5, H22 and H39),
4.29 (m, 1H, H48), 4.37–4.43 (m, 3H, H11, H28 and H45),
4.47–4.51 (m, 2H, H14 and H31), 5.04 (d, J = 12.3 Hz, 1H,
H53 CH2), 5.12 (d, J = 12.3 Hz, 1H, H53 CH2), 6.81 (d,
J = 7.2 Hz, 1H, H52), 7.33–7.37 (m, 5H, H53 Ar), 7.62 (d,
J = 7.9 Hz, 1H, H26), 7.67–7.75 (m, 4 H, H9, H18, H35 and
H43). IR (ATR, cmax cm-1) 3,292, 2,957, 1,666, 1,534,
1,392, 1,368. HRMS (ESI) calculated for C60H91N9O15
[M ? Na]? 1,200.6527; found: 1,200.6509.
20
½aꢁD -16.4 (c 0.57, CH2-Cl2) (see supplementary material
1
for numbering). H NMR (600 MHz; CDCl3): 0.93 (s, 3H,
H25), 0.95 (s, 3H, H8), 1.27 (s, 3H, H7), 1.31 (s, 3H, H24), 1.46
(s, 18H, H17 and H34), 2.10–2.20 (m, 4H, H4 proS, H15 proS
,
H21 proS and H32 proS), 2.24–2.27 (m, 1H, H15 proR), 2.32–2.45
(m, 4H, H4 proR, H20 proR, H21 proR and H32 proR), 2.63 (dd,
J = 10.1 Hz, J0 = 7.8 Hz, 1H, H3), 3.38 (d, J = 11.6 Hz,
1H, H13 proS), 3.45 (d, J = 11.5 Hz, 1H, H30 proS), 3.50–3.55
(m, 2H, H13 proR and H30 proR), 3.70 (s, 3H, H1), 4.02–4.07
(m, 2H, H5 and H22), 4.29 (m, 1H, H31), 4.45–4.50 (m, 2H,
Results and discussion
Scheme 1 shows the synthesis of both enantiomers 1 and 2
from (-)-verbenone as a common chiral precursor.
123